| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90348a429ffa25bbd39a647ab0d9173e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f8bda517c0c7d284e19cf5a4683977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_894a6ec85119974d5e2f56a6205f983a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f543fe4692b43c3acc978b785a389487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44f9cc0f06d5ad84089ab9407786f72 |
| publicationDate |
2022-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-115154469-A |
| titleOfInvention |
Application of Remegepam or its pharmaceutically acceptable salt in the preparation of medicine for preventing or treating obesity |
| abstract |
The present invention relates to the application of remegipam or a pharmaceutically acceptable salt thereof in the preparation of a medicament for preventing or treating obesity and related metabolic diseases. The present invention creatively finds that Remegepam or a pharmaceutically acceptable salt thereof can be used as a drug for preventing or treating obesity, which can significantly promote the browning of white adipocytes, and can also resist high-fat feed-induced browning in mice. Glucose intolerance and insulin resistance. The invention provides a theoretical basis for studying the treatment strategies of obesity and related metabolic diseases, and provides an embedding point for preparing new drugs for preventing or treating obesity and related metabolic diseases. |
| priorityDate |
2022-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |